Your browser doesn't support javascript.
loading
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
Tan, Yun; Liu, Feng; Xu, Xiaoguang; Ling, Yun; Huang, Weijin; Zhu, Zhaoqin; Guo, Mingquan; Lin, Yixiao; Fu, Ziyu; Liang, Dongguo; Zhang, Tengfei; Fan, Jian; Xu, Miao; Lu, Hongzhou; Chen, Saijuan.
Afiliação
  • Tan Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Liu F; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Xu X; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Ling Y; Shanghai Public Health Clinical Center, Shanghai, 201508, China.
  • Huang W; National Institutes for Food and Drug Control (NIFDC), Beijing, 102629, China.
  • Zhu Z; Shanghai Public Health Clinical Center, Shanghai, 201508, China.
  • Guo M; Shanghai Public Health Clinical Center, Shanghai, 201508, China.
  • Lin Y; Shanghai Public Health Clinical Center, Shanghai, 201508, China.
  • Fu Z; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Liang D; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Zhang T; Shanghai Public Health Clinical Center, Shanghai, 201508, China.
  • Fan J; Shanghai Public Health Clinical Center, Shanghai, 201508, China.
  • Xu M; National Institutes for Food and Drug Control (NIFDC), Beijing, 102629, China.
  • Lu H; Shanghai Public Health Clinical Center, Shanghai, 201508, China. luhongzhou@shphc.org.cn.
  • Chen S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. sjchen@stn.sh.cn.
Front Med ; 14(6): 746-751, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33017040
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Linfócitos T / Anticorpos Neutralizantes / Imunidade Adaptativa / SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Linfócitos T / Anticorpos Neutralizantes / Imunidade Adaptativa / SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China